In 2023, the import of cortisone, hydrocortisone, prednisone, and prednisolone to Italy stood at an estimated value of $19.481 million. The forecasted data from 2024 to 2028 shows a consistent yearly decline. From 2024 to 2028, the import values are expected to decrease steadily by approximately 0.5% per year. The compounded annual growth rate (CAGR) over this period is negative, highlighting a downtrend in imports.
Future trends to watch for include shifts in domestic production capabilities, potential regulatory changes in the pharmaceutical sector, and evolving demand for corticosteroid medications driven by demographic and health trends in Italy.
